National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 37755-37756 [2014-15424]
Download as PDF
<![CDATA[
37755
Federal Register / Vol. 79, No. 127 / Wednesday, July 2, 2014 / Notices
including your address to:
PATHprojectofficer@mail.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: Population
Assessment of Tobacco and Health
(PATH) Study—Second Wave of Data
Collection—0925–0664–Revision—
National Institutes of Health (NIH),
National Institute on Drug Abuse
(NIDA), in partnership with the Food
and Drug Administration (FDA).
Need and Use of Information
Collection: This is a revision request
(OMB 0925–0664, expires 11/30/2015)
for the Population Assessment of
Tobacco and Health (PATH) Study to
conduct the second wave of data
collection. The PATH Study is a large
behaviors and health effects within the
cohort over time. These data will help
to inform regulatory decisions and
actions by FDA.
OMB approval is requested for 3
years. There are no capital, operating, or
maintenance costs to report. There are
no costs to respondents other than their
time. The total estimated annualized
burden hours are 56,939. Factors
accounting for the difference between
the baseline and Wave 2 total hours
include the following: (1) Wave 2 does
not have a screening phase; (2) as
indicated in Supporting Statement B, a
86 percent response rate for adult
interviews and a 90 percent response
rate for youth interviews are projected
for Wave 2; and (3) fewer biological
samples will be collected in Wave 2.
national longitudinal cohort study on
tobacco use behavior and health among
the U.S. household population of adults
age 18 and older and youth ages 12 to
17. The PATH Study conducts annual
interviews and collects biospecimens
from adults to help inform the
development, implementation, and
evaluation of tobacco-product
regulations by FDA in meeting its
mission under the Family Smoking
Prevention and Tobacco Control Act
(TCA) to regulate tobacco products,
including tobacco-product advertising,
labeling, marketing, constituents,
ingredients, and additives. The
longitudinal design of the PATH Study
enables it to measure and report withinperson changes and between-person
differences in tobacco product use
ESTIMATED ANNUALIZED BURDEN HOURS
Estimated
number of
respondents
Type of respondent and
instrument
Adults—Extended Interview .............................................................................
Adults—Baseline youth respondents who age into adult cohort—Consent
for Extended Interview .................................................................................
Adults—Baseline youth respondents who age into adult cohort—Extended
Interview .......................................................................................................
Adults—Baseline youth respondents who age into the adult cohort—Consent for Biological Samples .........................................................................
Adults—Biospecimen Collection: Urine ...........................................................
Adults—Biospecimen Collection: Blood ...........................................................
Adults—Tobacco Use Form ............................................................................
Adults—Follow-up/Tracking Participant Information Form ..............................
Youth—Extended Interview .............................................................................
Youth—Shadow youth who age into youth cohort—Assent for Extended
Interview .......................................................................................................
Youth—Shadow youth who age into youth cohort—Extended Interview ........
Parent Interview ...............................................................................................
Parents of Shadow youth who age into youth cohort—Parent Permission
and Consent for Parent Interview ................................................................
Parents of Shadow youth who age into youth cohort—Parent Interview .......
Parents of youth—Follow-up/Tracking Participant Information Form for
Youth ............................................................................................................
Adults—Follow-up/Tracking Participant Information Form for sample Shadow youth (completed by parents) .................................................................
Estimated
number of
responses per
respondent
Average
burden hours
per response
Estimated
total annual
burden hours
requested
* 27,113
1
1
27,113
2,295
1
2/60
77
* 1,990
1
68/60
2,255
1,990
11,373
896
12,269
33,615
** 10,537
1
1
1
1
2
1
4/60
10/60
18/60
4/60
8/60
32/60
133
1,896
269
818
8,964
5,620
2,338
10,748
1
1
1
2/60
42/60
14/60
78
1,474
2,508
2,338
2,147
1
1
2/60
17/60
78
608
14,165
2
8/60
3,777
4,772
2
8/60
1,273
** 2,105
* Estimated
total number of adult extended interview respondents is 27,113 adults from Wave 1 + 1,990 youth from Wave 1 who turn 18 by
Wave 2 = 29,103.
**Estimated total number of youth extended interview respondents is 10,537 youth from Wave 1+ 2,105 shadow youth who turn 12 by Wave 2
= 12,642.
Dated: June 25, 2014.
Genevieve R. deAlmeida,
Project Clearance Liaison, National Institute
on Drug Abuse.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–15584 Filed 7–1–14; 8:45 am]
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
BILLING CODE 4140–01–P
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
VerDate Mar<15>2010
17:49 Jul 01, 2014
Jkt 232001
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Kidney Disease
Ancillary Studies.
E:\FR\FM\02JYN1.SGM
02JYN1
37756
Federal Register / Vol. 79, No. 127 / Wednesday, July 2, 2014 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
Date: July 23, 2014.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 753, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, (301) 594–8898,
barnardm@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Time-Sensitive
Obesity Prevention.
Date: July 30, 2014.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 753, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, (301) 594–8898,
barnardm@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, RFA–DK13–017
Human Islet Research Network Consortium
on Modeling Autoimmune Interactions
(HIRN–CMAI).
Date: August 4, 2014.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Ann A. Jerkins, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 759, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, 301–594–2242,
jerkinsa@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: June 26, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–15424 Filed 7–1–14; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
17:49 Jul 01, 2014
Jkt 232001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Ethical Issues Related to Central IRBs and
Research Using Clinical Records.
Date: July 8, 2014.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Denise Wiesch, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3138,
MSC 7770, Bethesda, MD 20892, (301) 437–
3478, wieschd@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Ethical Issues Related to Central IRBs and
Research Using Clinical Records.
Date: July 8, 2014.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Karin F Helmers, Ph.D.,
Scientific Review Officer, Center for
Scientific Review National Institutes of
Health, 6701 Rockledge Drive, Room 3144,
MSC 7770, Bethesda, MD 20892, (301) 254–
9975, helmersk@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Dated: June 26, 2014
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–15422 Filed 7–1–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Topics in Virology.
Date: July 22–23, 2014.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Marci Scidmore, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 301–435–
1149, marci.scidmore@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Neurological, Aging and
Musculoskeletal Epidemiology.
Date: July 22, 2014.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: George Vogler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3140,
MSC 7770, Bethesda, MD 20892, (301) 237–
2693, voglergp@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group AIDS
Discovery and Development of Therapeutics
Study Section.
Date: July 25, 2014.
Time: 8:00 a.m. to 5:00 p.m.
E:\FR\FM\02JYN1.SGM
02JYN1
]]>Agencies
[Federal Register Volume 79, Number 127 (Wednesday, July 2, 2014)]
[Notices]
[Pages 37755-37756]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-15424]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, Kidney Disease Ancillary
Studies.
[[Page 37756]]
Date: July 23, 2014.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Michele L. Barnard, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, (301)
594-8898, barnardm@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, Time-Sensitive Obesity
Prevention.
Date: July 30, 2014.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Michele L. Barnard, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, (301)
594-8898, barnardm@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, RFA-DK13-017 Human Islet
Research Network Consortium on Modeling Autoimmune Interactions
(HIRN-CMAI).
Date: August 4, 2014.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Ann A. Jerkins, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 759, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301-
594-2242, jerkinsa@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: June 26, 2014.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-15424 Filed 7-1-14; 8:45 am]
BILLING CODE 4140-01-P
